µÚËľüÒ½´óѧһ¾Å¾Å¶þÄê¹¥¶Á²©Ê¿Ñ§Î»Ñо¿ÉúÈëѧÊÔÌâ ѧ¿Æ×¨Òµ£º ic}TiTK
2aR9vmR
´«È¾²¡Ñ§ ¿¼ÊÔ¿ÆÄ¿: ÃâÒßѧ dYOY8r/
mc`Z;D/mt
Ò». Ãû´Ê½âÊÍ(ÿÌâ4·Ö,¹²32·Ö) RIUJX{?
I%:?f{\
1. ICAM-1 ->OVNmCB`+
%hmRh~/&
2. interleukin 12(IL-12) &'zc2
]iW:YNvXA
3. tumor infiltrating lymphocyte pdFO!A_t
'Qg!ww7O
4. TCR/CD3 complex MBj
Ae!,-
V=&M\58
5. hematopoietin receptor family [f {qb\
=rZ'!Pa
6. individual idiotype(IdI) !#%>,X#+
~s-gnp
7. integrin N)D+FV29y
KkTE -$-
8. colony-stimulatory factor (CSF) #Vmf
6
~
a4Y8r
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© qAd=i0{N
?Bq^#i|m
1. ÃâÒßÇòµ°°×ÖØÁ´µÄ»ùÒòÈçºÎ½øÐÐÀà±ðת»»(class switching )? zjow %
?%~^PHgZ|
2. ¼òÊöɱÉËÐÔTϸ°û(Tc)ɱÉ˲¡¶¾¸ÐȾ°Ðϸ°ûµÄ»úÀí¡£ a}FY^4hl+
JF~9efWe>
3. ÉúÎïÓ¦´ðµ÷½Ú¼Á( biological response modifier,BRM)Ö÷ÒªÓÐÄļ¸Àà?¼òÒª½éÉÜÔÚ´«È¾ÐÔ¼²²¡·ÀÖÎÖеÄ×÷Óᣠoj{CNa
!"yr;t>|Zb
4. ¼òÊö¿¹ÔÌá³Êϸ°û(APC)Ó븨ÖúÐÔTϸ°û(Th)Ï໥×÷ÓõĹØÏµ¡£ PCL
;Z
l(87s^_
Èý. ÎÊ´ðÌâ(ÿÌâ18·Ö,¹²36·Ö) -G/qfd|s/
t_!p({
1. ÊÔÊö¸ÉÈÅËØµÄ·ÖÀ༰ÆäÉúÎïѧ×÷ÓÃÌØµã¡£Ö÷Òª¿ÉÒÔÖÎÁÆÄÄЩ´«È¾ÐÔ¼²²¡?¼òÊö¸ÉÈÅËØ¼ì²âµÄ·½·¨ºÍÔÀí¡£ U$OI]Dd9
_#r00Ze
2. ºÎΪ»ùÒò¹¤³Ì¿¹Ìå?Ŀǰ¹úÄÚÍâÔÚ»ùÒò¹¤³Ì¿¹ÌåÑо¿ÖÐÓÐÄÄЩÖ÷Òª½øÕ¹? µÚËľüÒ½´óѧһ¾Å¾ÅÈýÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ ѧ¿Æ×¨Òµ: ´«È¾²¡Ñ§¡¢ Ïû»¯ÄÚ¿Æ ¿¼ÊÔ¿ÆÄ¿: ÃâÒßѧ Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© 1. CD4 2. T cell receptor(TCR) f@hM ^%
,YvOk|@R
3. immunoglobulin superfamily (IgSF) _A!Fp0}`
O<V 4j,
4. selectin }Md;=_TP
*{+{h;p
5. anti-idiotypic antibody (¦ÁId) Mh~}RA"H
?$
)5NQB%
6. major histocompatibility complex(MHC) a,S;JF)v
d,l?{Ln
7. immunotolerance ]OdZlZBsJ
N2'aC}
I
8. biological reponse modifier(BRM) P][jB
cXqYO|3/M
9. immune reponse gene (Ir gene) CKK}Z;~:
:[_msd
10. reshaped antibody (or reconstituted antibody) @
G)yz!H
U3V5Jor#
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© zX&SnT1~
I@9'd$YY
1. ¼òÊö°×ϸ°û½éËØ6(IL-6)Ö÷ÒªµÄÉúÎïѧ»îÐÔ¡£ m:?"|.
]
3)W zX
2. ϸ°û¶¾ÐÔTÁܰÍϸ°û(Tc»òCTL)Ó뿹ÌåÒÀÀµµÄϸ°û½éµ¼µÄϸ°û¶¾(ADCC)ɱÉË»úÀíÓкβ»Í¬? b@;Wh-{d
k[ro[E
3. ¼òÊöµÚ¢ôÐÍ(³Ù·¢ÐÍ)±ä̬·´Ó¦µÄ·¢Éú»úÀí¡£ W/ Q*NB
DpgTm&}-
4. NKϸ°ûÓÐÄÄЩÖ÷ÒªµÄ±íÃæ±ê¼Ç?NKϸ°ûÓÐÄÄЩÖ÷ÒªµÄÉúÎïѧ»îÐÔ? R03 Te gwA
@GFB{ ;=
Èý. ÎÊ´ðÌâ(ÿÌâ14·Ö,¹²28·Ö) ¹©´«È¾²¡Ñ§×¨ÒµÊÔÌ⣺ pqfX}x
}LT&BNZj
1. »úÌåÓÐÄÄЩÃâÒßϸ°ûºÍÃâÒß·Ö×Ó²ÎÓ뿹²¡¶¾¸ÐȾ?ËüÃÇÊÇÈçºÎ·¢»Ó²¡¶¾ÃâÒß×÷ÓõÄ? A<X?1$
aE`d[dSG
2. Ŀǰµ¥¿Ë¡¿¹ÌåÔÚ²¡¶¾Ñ§ÖÐÓÐÄÄЩÖ÷ÒªÓÃ;?½ñºó¿ÉÄÜÓÐÄÄЩÖ÷ÒªµÄ·¢Õ¹·½Ïò? ¡¡ Q<
:RLKVT
RPW46l34
¹©Ïû»¯ÄÚ¿Æ×¨ÒµÊÔÌ⣺ =+!l8o&o,
K] (*l"'U5
1. ĿǰÌåÄÚºÍÌåÍâ¼ì²âÖ×Áö»¼ÕßÃâÒß¹¦Äܵķ½·¨Ö÷ÒªÓÐÄÄЩ?·Ö±ðÐðÊöÿÖÖ·½·¨µÄÔÀíºÍ½á¹û²â¶¨? cg MF?;V
a]T:wUYG'
2. Ŀǰµ¥¿Ë¡¿¹ÌåÔÚÖ×ÁöѧÖÐÓÐÄÄЩÖ÷ÒªµÄÓÃ;?½ñºó¿ÉÄÜÓÐÄÄЩÖ÷ÒªµÄ·¢Õ¹·½Ïò? ¡¡ Oo|PZ_P
pUXoSnIq:
µÚËľüÒ½´óѧһ¾Å¾ÅËÄÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ ѧ¿Æ×¨Òµ: gYB!KM *v
}~/b%^
´«È¾²¡Ñ§¡¢ Ïû»¯ÄÚ¿Æ ¿¼ÊÔ¿ÆÄ¿: X/,)KTo7
aj1]ZT\
̉񧄤 4 O!2nP
N,Eap K
G
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© +i&<`ov
J-v1"7[2GC
1. CD8 <